XML 187 R5.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Revenue      
Total revenue $ 1,144,163 $ 773,915 $ 687,180
Operating expenses      
Cost of services, excluding depreciation and amortization 944,685 596,142 539,211
General and administrative expenses 77,670 62,077 49,116
Depreciation and amortization 17,543 17,517 18,350
Total expenses 1,039,898 675,736 606,677
Income from operations 104,265 98,179 80,503
Other (expense) income      
Income (loss) from equity method investments 5,622 (4,306) 3,694
Gain on sale of equity method investment 0 2,193 99,839
Interest expense (7,920) (5,394) (9,499)
Interest income 1,976 1,571 2,813
Unrealized loss on investments (21,271) (10,745) 0
Other income (expense) 3,944 (3,750) 1,077
Total other (expense) income, net (17,649) (20,431) 97,924
Income before provision for income taxes 86,616 77,748 178,427
Provision for income taxes 36,085 28,454 56,107
Net income 50,531 49,294 122,320
Net income (loss) attributable to noncontrolling interests 1,482 (24,564) 84,454
Net income attributable to Apollo Medical Holdings, Inc. $ 49,049 $ 73,858 $ 37,866
Earnings per share – basic (in dollars per share) $ 1.09 $ 1.69 $ 1.04
Earnings per share – diluted (in dollars per share) $ 1.08 $ 1.63 $ 1.01
Capitation, net      
Revenue      
Total revenue $ 930,131 $ 593,224 $ 557,326
Risk pool settlements and incentives      
Revenue      
Total revenue 117,254 111,627 77,367
Management fee income      
Revenue      
Total revenue 41,094 35,959 34,850
Fee-for-service, net      
Revenue      
Total revenue 49,517 26,564 12,683
Other income      
Revenue      
Total revenue $ 6,167 $ 6,541 $ 4,954